Search results for "Vaccines"
The ethical nexus of health care: Purpose over profit
ACP is comprehensively examining the corrosive impact of profit-driven health care on the sacred patient-physician relationship in order to pave the way for potential solutions.
https://immattersacp.org/archives/2024/02/the-ethical-nexus-of-health-care-purpose-over-profit.htm
1 Feb 2024
High-dose flu vaccine may not be more effective than standard dose in patients with high-risk cardiovascular disease
An industry-funded randomized trial in the U.S. and Canada found no significant difference between a high-dose group versus a standard-dose group in the time to first occurrence of all-cause death or cardiopulmonary hospitalization during three flu seasons.
https://immattersacp.org/weekly/archives/2020/12/15/5.htm
15 Dec 2020
Getting patients to ‘yes' on COVID-19 vaccines
Experts believe practicing physicians are well positioned to take a lead role combating one of the biggest anticipated obstacles to widespread vaccination: vaccine hesitancy.
https://immattersacp.org/archives/2021/01/getting-patients-to-yes-on-covid-19-vaccines.htm
1 Jan 2021
Interim data find vaccine 66% to 85% effective against symptomatic RSV in older adults
The results from a large ongoing phase 3 trial show success in protection from respiratory syncytial virus (RSV)-associated lower respiratory tract illness on two important primary endpoints, although reductions in hospitalization and death have yet to be shown.
https://immattersacp.org/weekly/archives/2023/04/11/1.htm
11 Apr 2023
Keep up with vaccine recommendations
New vaccines and their recommendations have added complexity and made it tough to stay current. For patients, the extra costs can be prohibitive. Learn how to stay abreast of the requirements and engage patients on the issue.
https://immattersacp.org/archives/2013/09/vaccines.htm
1 Sep 2013
Hepatitis B vaccine now recommended for adults ages 19 through 59 years
The Advisory Committee on Immunization Practices has changed its guidance to encourage clinicians to offer the vaccine to adult patients, rather than target those with risk factors or wait for it to be requested.
https://immattersacp.org/weekly/archives/2022/04/05/1.htm
5 Apr 2022
Allergy may not be absolute obstacle to COVID-19 vaccine
Allergic reactions to COVID-19 vaccines are rare but remain a source of concern. Experts at a recent conference offered some advice on management.
https://immattersacp.org/archives/2021/04/allergy-may-not-be-absolute-obstacle-to-covid-19-vaccine.htm
1 Apr 2021
Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
https://immattersacp.org/weekly/archives/2021/09/14/2.htm
14 Sep 2021
CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants
The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
https://immattersacp.org/weekly/archives/2023/01/24/2.htm
24 Jan 2023
Looking ahead at the past
ACP membership inspires through its principles, opportunities, and relevance.
https://immattersacp.org/archives/2024/01/looking-ahead-at-the-past.htm
1 Jan 2024